Cargando…
Self-Assembled Lecithin-Chitosan Nanoparticles Improved Rotigotine Nose-to-Brain Delivery and Brain Targeting Efficiency
Rotigotine (RTG) is a non-ergoline dopamine agonist and an approved drug for treating Parkinson’s disease. However, its clinical use is limited due to various problems, viz. poor oral bioavailability (<1%), low aqueous solubility, and extensive first-pass metabolism. In this study, rotigotine-loa...
Autores principales: | Saha, Paramita, Singh, Prabhjeet, Kathuria, Himanshu, Chitkara, Deepak, Pandey, Murali Monohar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052746/ https://www.ncbi.nlm.nih.gov/pubmed/36986712 http://dx.doi.org/10.3390/pharmaceutics15030851 |
Ejemplares similares
-
Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery
por: Tzeyung, Angeline Shak., et al.
Publicado: (2019) -
Preparation and characterisation of PHT-loaded chitosan lecithin nanoparticles for intranasal drug delivery to the brain
por: Yousfan, Amal, et al.
Publicado: (2020) -
Self-Assembling Lecithin-Based Mixed Polymeric Micelles for Nose to Brain Delivery of Clozapine: In-vivo Assessment of Drug Efficacy via Radiobiological Evaluation
por: M Elsharkawy, Fatma, et al.
Publicado: (2023) -
Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects
por: Yan, Xiuju, et al.
Publicado: (2018) -
Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation
por: Liu, Liyao, et al.
Publicado: (2016)